Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Pentair Announces Early Termination Of HSR Act Waiting Period

RELATED NEWS
Trade PNR now with 

Pentair, Inc. (PNR: Quote) said Wednesday that it has received notification of early termination of the U.S. antitrust waiting period in connection with the proposed deal to combine the flow control business of Tyco International Ltd. (TYC: Quote) with Pentair in a tax-free, all-stock merger.

The deal was announced last month.

The expiration of the HSR Act waiting period satisfies one of the conditions to closing of the merger, which remains subject to approval of the spin-off by Tyco shareholders, the approval of the merger by Pentair shareholders, foreign regulatory approvals and other customary closing conditions.

Click here to receive FREE breaking news email alerts for Pentair Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.